Guidance of intracoronary radiation therapy based on dose-volume histograms derived from quantitative intravascular ultrasound

Application of ionizing radiation to prevent restenosis in atherosclerotic vessels treated by balloon angioplasty is a new treatment under investigation in interventional cardiology and radiology. There is variability in dose prescription, and both /spl gamma/- and /spl beta/-emitters are used, lead...

Full description

Saved in:
Bibliographic Details
Published inIEEE transactions on medical imaging Vol. 17; no. 5; pp. 772 - 778
Main Authors Carlier, S.G., Marijnissen, J.P.A., Coen, V.L.M.A., van der Giessen, W.J., Sabate, M., Ligthart, J., den Boer, A., Cespedes, I.E., Wenguang Li, van der Steen, A.F.W., Levendag, P.C., Serruys, P.W.
Format Journal Article
LanguageEnglish
Published United States IEEE 01.10.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Application of ionizing radiation to prevent restenosis in atherosclerotic vessels treated by balloon angioplasty is a new treatment under investigation in interventional cardiology and radiology. There is variability in dose prescription, and both /spl gamma/- and /spl beta/-emitters are used, leading to a wide range of dose distribution over the arterial vessel wall. The authors present a new modality of dosimetry based on a method that three-dimensional (3-D) image reconstruction of electrocardiogram (ECG)-gated intravascular ultrasound (IVUS) images. Dose volume histograms (DVH) are used to describe the cumulative distribution of dose over two specific volumes: i) at the level of the luminal surface, defined with a thickness of 0.1 mm from the automatically detected contour of the highly echogenic blood-vessel interface, and ii) the adventitia volume is computed considering a 0.5-mm thickness from the echogenic media-adventitia interface. DVH provide a tool for reporting the actual delivered dose at the site believed to be the target: the adventitia, and to detect excessive radiation which could lead to vascular complications. Simulation of a /spl gamma/-emitter or of a radioactive source train in the center of the lumen are possible. The data obtained from the first ten patients included in the /spl beta/-irradiation trial (BERT 1.5) conducted in the authors' institution are presented, supporting the use of DVH based on quantitative IVUS measurements for optimal dose prescription in vascular interventional radiation therapy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0278-0062
1558-254X
DOI:10.1109/42.736033